Chord Therapeutics
Description: Chord Therapeutics develops drugs for rare, life-threatening diseases, focusing on CRD1 for neuromyelitis optica & myasthenia gravis.
Country: Switzerland
Based in: Geneva
Founded: 2014
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Pharmaceutical']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.